Drug
HRS-8080 clinical trials
Also written HRS-8080.
- studies test it
- 11
- open now
- 9
- in phase 3
- 3
- first study started
- 2022
Keep track of what changes. Save the HRS-8080 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
11 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 4
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Itraconazole (1) · Rifampin (1) · Fulvestrant (1) · Letrozole (1) · HRS-6209 (1) · HRS-1358 (1) · Ruzaltatug rezetecan (1) · Adebrelimab (1)
Studies
Open first, then newest update. How each study uses HRS-8080 is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Drug-Drug Interaction Study of Rifampicin and Oral HRS-8080Not yet recruitingPhase 1Shandong Suncadia Medicine Co., Ltd.NCT07876596Written as HRS-8080
- A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast CancerRecruitingPhase 3Shandong Suncadia Medicine Co., Ltd.NCT07024173Written as HRS-8080 Tablet
- A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.RecruitingPhase 3Shandong Suncadia Medicine Co., Ltd.NCT07354022Written as HRS-8080 Tablet ; Dalpiciclib Isethionate
- A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast CancerRecruitingPhase 3Shandong Suncadia Medicine Co., Ltd.NCT07349069Written as HRS-8080 Tablets
- A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast CancerRecruitingPhase 1/2Shandong Suncadia Medicine Co., Ltd.NCT07389733Written as HRS-8080 Tablet
- A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer PatientsRecruitingPhase 1/2Shandong Suncadia Medicine Co., Ltd.NCT06679036Written as HRS-8080
- Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast CancerRecruitingPhase 1/2Shandong Suncadia Medicine Co., Ltd.NCT06167694Written as HRS-8080; Dalpiciclib Isethionate Tablets
- Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast CancerRecruitingPhase 1/2Shandong Suncadia Medicine Co., Ltd.NCT06222879Written as HRS-8080; SHR-A1811
- A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of AdultsEnrolling by invitationPhase 1Shandong Suncadia Medicine Co., Ltd.NCT05189717Written as HRS-8080 tablets、SHR 6390 tablets、Abemaciclib、Everolimus
- A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy SubjectsCompletedPhase 1Shandong Suncadia Medicine Co., Ltd.NCT06619873Written as HRS-8080
- A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy ParticipantsCompletedPhase 1Shandong Suncadia Medicine Co., Ltd.NCT07229560Written as HRS-8080 Tablet